Abstract:
The invention relates to polypeptides that block or inhibit the interleukin-1 receptor 1 (IL-1R1), the interaction of IL-1beta with IL-1R1 or the interaction between IL-1R1 and interleukin-1 receptor accessory protein (IL-1RaCP). The invention relates specifically to therapeutic polypeptides that target specifically IL-1R1 present on tumor cells, cancer stem cells, and cancer stem cells which are resistant to chemotherapy or radiotherapy. The invention specifically relates to cancer stem cells (CSC) that express IL-1R1 to which said inhibitors bind. Finally the invention relates to a combination therapy comprising killing tumorigenic differentiating cancer cells by means of standard chemo- or radiotherapy and prior or subsequent to that applying IL-1R1 inhibitors which target specifically CSC and strip the tumor of its capacity to generate cancer cell progeny.
Abstract:
The present invention relates to systems, methods, and apparatuses for the management, distribution, dispensing, and administration of consumer products, including over-the-counter and prescription medications through use of a product container labeling system and an optional integrated computer-based or online management system. In certain aspects, the invention relates to a product container comprising a hollow body, a child-resistant cap, and a specialized information label affixed to the hollow body.
Abstract:
A method and system for collecting installed application data from a computer system. The method includes scanning a file system of the computer system to produce file system data, and scanning an installed application database of the computer system to produce installed application data. The method further includes collecting system information associated with the computer system. The method still further includes combining the file system data, the application data, and the system information to produce an output file.
Abstract:
Novel triazole derivatives of the formula (I) in which R1-R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Abstract:
A device for charging a battery system having a number of individual voltage sources situated in a series circuit is provided, which device uses a voltage source and a respective bypass associated with each of the individual voltage sources. A charge current IL is supplied from the voltage source via the bypasses to the individual voltage sources as a function of their charge condition.
Abstract:
Novel adenine derivatives of the formula (I), in which R1, R2, R3, X and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Abstract:
A method for repairing a pipeline by means of at least one shell that is adapted to the outer contour of the pipeline, wherein the at least one shell is attached to the outer wall of the pipeline using an intermediate layer between the interior of the shell and the outer wall of the pipeline. The intermediate layer is made of an adhesive that can be activated, which is used to substantially completely coat the interior of the at least one shell. The attachment of the shell is carried out by applying a force acting at least in the radial direction, and the activation of the adhesive. A shell that is coated in this manner is also disclosed.
Abstract:
Novel phenylquinazoline derivatives of the formula (I), in which R1, R2, R3, R4 and R5 have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Abstract:
Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R1-R6 have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Abstract:
The invention concerns a fuel filter 10, in particular for diesel fuels, that comprises a housing 11 and a filter medium 12. The filter medium 12 is arranged by means of a filter medium holder 24 in the housing, wherein the filter medium holder comprises a venting bore 25. Through the venting bore 25 gases that collect in the upper area of the fuel filter can pass from the crude chamber 21 into the clean chamber 22. For avoiding that contaminants can escape through a clean outlet 18 from the fuel filter 10 and damage components downstream, a clean medium 26 is provided that retains such contaminants.